Abstract:Papillomaviruses are viruses with double-stranded DNA that are epitheliotropic and non-enveloped that infects cutaneous epithelial and mucosal cells in a species-specific way in several higher vertebrate species and cause cellular growth."There are around 100 different human papillomaviruses (HPVs)", as "more than 150 HPV types have been isolated and fully sequenced". We classify the probability of cancer development following viral infection with each HPV genotype into two types: "low-risk" and "high-risk." As a result, HPV diagnosis is a critical component of HPV genotype identification and characterization. Based on its activities, we may classify the HPV genome into three regions: the long control region (LCR) or the non-coding upstream regulatory region (URR), the late (L) region, and the early (E) region. Functional proteins are mostly static things that are not inflexible; they have undergone both local and global movements at various times and time ranges. The structural differences between HPV16 and 18 discovered by molecular modeling of the E6 oncoprotein were associated with their carcinogenic characteristics. Similarly, the E6 protein has two sets of C-X-X-C motifs that play significant roles in transformation, transcriptional activation, interactions, and immortalization with other proteins of cells in the host environment. Here, we review the literature regarding the protein mechanisms associated with HPV and how they cause cancer. Unless otherwise noted, it described all protein activities in terms of HPV proteins. The term "papillomaviruses" refers to groups of papillomavirus proteins that have a characteristic in common. HPV proteins can study the genetic influences on pathogenicity and the therapeutic applications of genomics. The future study provides a potential advancement in HPV infections and malignant illnesses to improve preventive and treatment strategies. Patients have been able to conquer this condition using a range of therapies and vaccines that were projected to be effective and robust enough to put an end to the ailment completely. In cancer prevention strategies, HPV vaccination is one of the most effective. It is safe, efficient, and long-lasting.

Progress in Human Papillomavirus-Induced Oncogenesis

Toll-Like Receptors in Human Papillomavirus Infection

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Human Papillomavirus Infection and Host Immune Response

Human papillomavirus infection and host innate immune responses

Development of Human Papillomavirus Detection

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

[Research on the Oncogenesis of Cervical Epithelial Cells Co-Induced by Human Papillomavirus and Human Cytomegalovirus].

Human papillomavirus molecular biology and disease association

Papillomaviruses and cancer: from basic studies to clinical application

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins

Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management

The Study of Human Papillomavirus Genotyping in Cervical Cancer

Advances of Cytokeratin Promoters in HPV Transgenic Mice

Structural biology of the human papillomavirus

Human Papillomavirus: It’s Characteristics, Pathogenesis, Transmission, Immunity, and it’s Role in Cervical Cancer: A Mini Review

HPV-associated diseases of the oral mucosa

Potential role of human papillomavirus proteins associated with the development of cancer